Hoth Therapeutics receives Nasdaq delisting notice for bid price below $1.00

Hoth Therapeutics, Inc.

Closing bid price of common stock below $1.00 for 30 consecutive business days ending May 12, 2025.
Company has 180 days, until November 10, 2025, to regain compliance with minimum bid price rule.
To cure, stock must close at or above $1.00 for at least 10 consecutive business days.
Company may consider a reverse stock split among available options to regain compliance.
Nasdaq notice has no immediate effect on trading; stock continues on Nasdaq Capital Market under HOTH.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.